相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment
Gregory S. Calip et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use
Michelle D. Holmes et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age
Jean A. McDougall et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Frequent Antibiotic Use and Second Breast Cancer Events
Heidi S. Wirtz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
Gitte Vrelits Sorensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort
Stefan Nickels et al.
PLOS ONE (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
Young Kwang Chae et al.
JOURNAL OF CANCER (2013)
Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years
Christopher I. Li et al.
JAMA INTERNAL MEDICINE (2013)
Statin use and risk of breast cancer: a meta-analysis of observational studies
Krishna Undela et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
Patricia A. Ganz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
Young Kwang Chae et al.
CANCER INVESTIGATION (2011)
Beta Blockers and Breast Cancer Mortality: A Population-Based Study
Thomas I. Barron et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Multimorbidity: An Issue of Growing Importance for Oncologists
Christine S. Ritchie et al.
JOURNAL OF ONCOLOGY PRACTICE (2011)
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Erica K. Sloan et al.
CANCER RESEARCH (2010)
Statin use and cancer risk: a comprehensive review
Denise M. Boudreau et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates
Amanda I. Phipps et al.
MATURITAS (2010)
Evaluating Health Outcomes in the Presence of Competing Risks A Review of Statistical Methods and Clinical Applications
Ravi Varadhan et al.
MEDICAL CARE (2010)
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
Desmond G. Powe et al.
ONCOTARGET (2010)
The renin-angiotensin system and cancer: old dog, new tricks
Amee J. George et al.
NATURE REVIEWS CANCER (2010)
Is norepinephrine an etiological factor in some types of cancer?
Paul J. Fitzgerald
INTERNATIONAL JOURNAL OF CANCER (2009)
Angiotensin inhibition and malignancies: a review
T. Rosenthal et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Association of Cardiometabolic Risk Factors and Prevalent Cardiovascular Events
Dan C. Malone et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
Health Care Utilization and Costs by Metabolic Syndrome Risk Factors
D. M. Boudreau et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care
Diana S. M. Buist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study
Soe Soe Thwin et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
Clifford A. Hudis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Recurrences and second primary breast cancers in older women with initial early-stage disease
Ann M. Geiger et al.
CANCER (2007)
Breast cancer treatment of older women in integrated health care settings
Shelley M. Enger et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A population-based osteoporosis screening program: Who does not participate, and what are the consequences?
DSM Buist et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Impact of healthcare delivery system on where HMO-enrolled seniors purchase medication
DM Boudreau et al.
ANNALS OF PHARMACOTHERAPY (2004)
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs
K Lang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells
TL Drell et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Pharmacologic characteristics of statins
JM McKenney
CLINICAL CARDIOLOGY (2003)
Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists
A Molteni et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care - The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
CD Furberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Carcinogenicity of antihypertensive therapy
E Grossman et al.
CURRENT HYPERTENSION REPORTS (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:: an in vitro study
C Denoyelle et al.
CARCINOGENESIS (2001)
Antihypertensive therapy and cancer risk
DC Felmeden et al.
DRUG SAFETY (2001)
分享论文
